Artificial intelligence is beginning to reshape how drug companies interact with the Food and Drug Administration, though most changes so far have been limited.

Liver disease is a growing health concern in the United States, affecting millions of adults. One of the most common types is ...

The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in ...

Under Proposition 36, the District Attorney has significantly increased felony convictions. But a part of the bill that ...

The drug is already approved for KMT2A-rearranged AML, and Syndax is hoping for approval in NPM1-mutated disease by the end of the year.

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

Costa Rica’s US-donated drug scanners remain unused seven months after arrival, delaying port security upgrades at Caldera ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

The integration of Artificial Intelligence (AI) in various sectors has been nothing short of transformative, and now, it’s poised to ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...